Oncodesign Precision Medicine (XPAR:ALOPM) Receivables Turnover : 1.11 (As of Jun. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Oncodesign Precision Medicine's Revenue for the six months ended in Jun. 2022 was €0.44 Mil. Oncodesign Precision Medicine's average Accounts Receivable for the six months ended in Jun. 2022 was €0.40 Mil. Hence, Oncodesign Precision Medicine's Receivables Turnover for the six months ended in Jun. 2022 was 1.11.

Oncodesign Precision Medicine Receivables Turnover Historical Data

The historical data trend for Oncodesign Precision Medicine's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Receivables Turnover Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Receivables Turnover

5.13

6.31

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22
Receivables Turnover	-	-	1.11

Competitive Comparison of Oncodesign Precision Medicine's Receivables Turnover

For the Biotechnology subindustry, Oncodesign Precision Medicine's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Receivables Turnover falls into.

Oncodesign Precision Medicine Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Oncodesign Precision Medicine's Receivables Turnover for the fiscal year that ended in Dec. 2021 is calculated as

	Receivables Turnover (A: Dec. 2021 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2021 )	/ (	(Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Dec. 2021 ))	/	count )
=	3.831	/ (	(0.859	+	0.355)	/	2 )
=	3.831	/	0.607
=	6.31

Oncodesign Precision Medicine's Receivables Turnover for the quarter that ended in Jun. 2022 is calculated as

	Receivables Turnover (Q: Jun. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2022 )	/ (	(Accounts Receivable (Q: Dec. 2021 )	+	Accounts Receivable (Q: Jun. 2022 ))	/	count )
=	0.439	/ (	(0.355	+	0.439)	/	2 )
=	0.439	/	0.397
=	1.11

Oncodesign Precision Medicine (XPAR:ALOPM) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Oncodesign Precision Medicine Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines